LRRK2 gene variant may be cause of Parkinson’s in Europe: Study
A rare mutation in the LRRK2 gene found in 17 individuals with Parkinson’s disease or a family history of…
Articles by Margarida Maia, PhD
Tremor in older adults ID’d as Parkinson’s risk factor in new study
Older adults with tremor are three times more likely than those in the general elderly population to develop Parkinson’s…
NDC-0524 for Parkinson’s may enter clinical testing in late 2025
NDC-0524, an experimental antibody that Nitrase Therapeutics is developing as a treatment for people with Parkinson’s disease, is…
Eye test may detect early retinal changes in Parkinson’s: Study
Parkinson’s disease can lead to early retinal changes — alterations in the thin layer at the back of the…
1st look at PINK1 structure reveals Parkinson’s clues
Researchers for the first time visualized how PINK1, a protein linked to early-onset Parkinson’s disease, binds to mitochondria and…
Gut neurons may offer way to treat constipation in Parkinson’s: Study
Neurons, or nerve cells, that release a signaling molecule called glutamate within the enteric nervous system — a network of…
First Parkinson’s patient dosed in GT-02287 clinical trial
The first patient has been dosed in Gain Therapeutics‘ clinical trial of GT-02287, an investigational, oral small molecule being…
Genetic disease offers insights for Parkinson’s treatmentÂ
A rare nerve disorder may offer clues to potential Parkinson’s disease treatment targets, a mouse study showed. In giant…
Company repurposing anticancer medication RB-190 for Parkinson’s
Right Brain Bio is repurposing the approved therapy RB-190 as a treatment for Parkinson’s disease — and is…
ASAP seeks applications for $6M in Parkinson’s research grants
Note: This story was updated March 17, 2025, to correct the attribution of quotes to Sonya Dumanis, PhD, deputy director…